Correlations.

<div><p>Background</p><p>Variational AutoEncoders (VAE) might be utilized to extract relevant information from an IMU-based gait measurement by reducing the sensor data to a low-dimensional representation. The present study explored whether VAEs can reduce IMU-based gait data of people after stroke into a few latent features with minimal reconstruction error. Additionally, we evaluated the psychometric properties of the latent features in comparison to gait speed, by assessing 1) their reliability; 2) the difference in scores between people after stroke and healthy controls; and 3) their responsiveness during rehabilitation.</p><p>Methods</p><p>We collected test-retest and longitudinal two-minute walk-test data using an IMU from people after stroke in clinical rehabilitation, as well as from a healthy control group. IMU data were segmented into 5-second epochs, which were reduced to 12 latent-feature scores using a VAE. The between-day test-retest reliability of the latent features was assessed using ICC-scores. The differences between the healthy and the stroke group were examined using an independent t-test. Lastly, the responsiveness was determined as the number of individuals who significantly changed during rehabilitation.</p><p>Results</p><p>In total, 15,381 epochs from 107 people after stroke and 37 healthy controls were collected. The VAE achieved data reconstruction with minimal errors. Five latent features demonstrated good-to-excellent test-retest reliability. Seven latent features were significantly different between groups. We observed changes during rehabilitation for 21 and 20 individuals in latent-feature scores and gait speed, respectively. However, the direction of the change scores of the latent features was ambiguous. Only eleven individuals exhibited changes in both latent-feature scores and gait speed.</p><p>Conclusion</p><p>VAEs can be used to effectively reduce IMU-based gait assessment to a concise set of latent features. Some latent features had a high test-retest reliability and differed significantly between healthy controls and people after stroke. Further research is needed to determine their clinical applicability.</p></div>